Please use this identifier to cite or link to this item:
|Title:||Systematic evolution of ligands by exponential enrichment: tissue selex|
|Assignee:||NeXstar Pharmaceuticals, Inc.|
|Contributor:||Swanson & Bratschun. LLC|
Swanson & Bratschun. LLC
|Inventors: Jensen; Kirk B., Chen; Hang, Morris; Kevin N., Stephens; Andrew, Gold; Larry. Assignee: Nexstar Pharmaceuticals, Inc. Agents: Swanson & Bratschun. LLC|
|Abstract:||This invention discloses high-affinity oligonucleotide ligands to complex tissue targets, specifically nucleic acid ligands having the ability to bind to complex tissue targets, and the methods for obtaining such ligands. Tissue targets comprise cells, subcellular components, aggregates or cells, collections of cells, and higher ordered structures. Specifically, nucleic acid ligands to red blood cells ghosts, glioblastomas, and lymphomas are described.|
|Description:||Publication number US5789157 A Publication type Grant Application number US 08/434,425 Publication date Aug 4, 1998 Filing date May 3, 1995 Priority date Jun 11, 1990|
|Patent #:||US5789157 A|
|Appears in Collections:||Molecular and Biomedical Science publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.